Literature DB >> 8477692

Chymotryptic cleavage of lipoprotein lipase. Identification of cleavage sites and functional studies of the truncated molecule.

A Lookene1, G Bengtsson-Olivecrona.   

Abstract

Treatment of bovine lipoprotein lipase (LPL) with chymotrypsin results in cleavage between residues Phe390-Ser391 and between Trp392-Ser393, indicating that this region is exposed in the native conformation of LPL. Two main fragments are generated, one large including the amino-terminus (chymotrypsin-truncated LPL = c-LPL) and one small, carboxy-terminal fragment. The small fragment is not stable, but is further degraded by the protease. Isolated c-LPL has full catalytic activity against tributyryl glycerol (tributyrin) and p-nitrophenyl butyrate, while the activity against emulsions of long-chain triacylglycerols and against liposomes is reduced and the activity against milk fat globules and chylomicrons is lost. Several properties of c-LPL were investigated. It was found that c-LPL interacts with apolipoprotein CII (apo CII) as efficiently as intact LPL. The truncated enzyme bound to liposomes and to emulsions of long-chain triacylglycerols as well as the intact enzyme did. In contrast, c-LPL did not bind to milk fat globules or to chylomicrons. The activity of c-LPL was more sensitive to inhibition by other lipid-binding proteins, e.g. apolipoprotein CIII (apo CIII), than was the intact enzyme. The affinity for heparin was as high with c-LPL as with intact LPL. Like intact LPL, c-LPL is dimeric in its active form, as evidenced by sucrose density gradient centrifugation. It is concluded that the reduced catalytic and lipid-binding properties of c-LPL compared with intact LPL are related to the properties of the substrate interface. It is speculated that the carboxy-terminal part of LPL contains a secondary lipid-binding site, which is important for activity against chylomicrons and related substrates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477692     DOI: 10.1111/j.1432-1033.1993.tb17747.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Authors:  Ming Jing Wu; Anna Wolska; Benjamin S Roberts; Ellis M Pearson; Aspen R Gutgsell; Alan T Remaley; Saskia B Neher
Journal:  J Lipid Res       Date:  2018-10-14       Impact factor: 5.922

2.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

3.  Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.

Authors:  Esther M M Ooi; Betsy S Russell; Eric Olson; Sam Z Sun; Margaret R Diffenderfer; Alice H Lichtenstein; Leonard Keilson; P Hugh R Barrett; Ernst J Schaefer; Dennis L Sprecher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

Review 4.  GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

Authors:  Stephen G Young; Loren G Fong; Anne P Beigneux; Christopher M Allan; Cuiwen He; Haibo Jiang; Katsuyuki Nakajima; Muthuraman Meiyappan; Gabriel Birrane; Michael Ploug
Journal:  Cell Metab       Date:  2019-07-02       Impact factor: 27.287

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.